RADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2025. Second Quarter Highlights: Revenue was $104.6 million, compared to$93.3 million in the second quarter of 2024, representing growth of 12%. Software revenue was $46.7 million, compared to$38.2 million in the second quarter of 2024, representing growth of 22%.Service revenue was $57.9 million, compare ...